Latest Insider Transactions at Apellis Pharmaceuticals, Inc. (APLS)
This section provides a real-time view of insider transactions for Apellis Pharmaceuticals, Inc. (APLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apellis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apellis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2017
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,071,428
+23.57%
|
$14,999,992
$14.0 P/Share
|
|
Nov 13
2017
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,402,497
+50.0%
|
-
|
|
Nov 13
2017
|
Aju Ib Investment Co., Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,292,062
+50.0%
|
-
|